VolitionRx Limited ("Volition"), a multi-national epigenetics company, today announces two poster presentations at the European Society for Medical Oncology (ESMO)'s European Lung Cancer Congress 2025 ...

The global in vitro diagnostics market (IVD) was valued at $67,111 million in 2019, and is projected to reach $91,093 million at a CAGR of 4.8% from 2020 to 2027. For instance, in clinical chemistry ...

The global coronavirus immunoassay market continues to witness steady growth, reaching USD 3.7 billion in 2021 and is projected to exceed USD 6.9 billion by 2032, expanding at a CAGR of 5.5% during ...

VolitionRx (VNRX) announces the results of a study which shows that an automated Nu.Q Cancer immunoassay test in development detected a range ...

VolitionRx Limited (NYSE AMERICAN: VNRX) ('Volition'), a multi-national epigenetics company, today announces the results of a study which shows that an automated Nu.Q® Cancer immunoassay test in ...

Report Ocean is delighted to unveil an exhaustive analysis of the Philippines Diagnostic Testing Market, presenting a detailed exploration of its various dimensions from 2018 to 2032. Our in-depth ...

VolitionRx (VNRX) announced the expansion of its Nu.Q Vet Cancer Test supply agreement with Fujifilm Vet Systems in Japan, to include ...

BosterBio’s expertise in antibody production and its exceptional technical support and educational resources make it a trusted partner for researchers in academia, pharmaceuticals, and biotechnology.

There are several types of these tests. An immunoassay (IA) test is most common because it is the quickest and most cost-effective. However, IA tests can give false-positive results. In this case ...

The US Food and Drug Administration (FDA) has granted 510(k) clearance to Beckman Coulter Diagnostics' new DxC 500i Clinical Analyzer. The integrated clinical chemistry and immunoassay analyser claims ...

With throughput of up to 800 clinical chemistry tests per hour and 100 immunoassay tests per hour, this analyzer delivers precise and reliable results critical for timely clinical decision-making.